Fe–Au Nanoparticle‐Coupling for Ultrasensitive Detections of Circulating Tumor DNA
Authors:
- 22 June 2018
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 30 (31) , e1801690
Abstract
Effectiveness of cancer therapy relies heavily on the efficient early diagnosis. Circulating tumor DNA (ctDNA) detection is one of the most clinically meaningful liquid biopsy approaches for the noninvasive cancer early diagnosis, which, unfortunately, cannot be applied as a routine diagnostic tool till a number of obstacles, for example, unsatisfactory specificity and sensitivity, and extremely high costs, are overcome. Here, the first paradigm of nanomaterial's application in the extremely specific, ultrasensitive, and yet economical ctDNA detections is reported based on a facile nanoparticle‐coupling strategy without amplification, with which polymerase chain reaction (PCR)‐introduced bias and other shortcomings are successfully circumvented. Aiming at seven Kirsten rat sarcoma‐2 virus (KRAS) point mutations, the present strategy exhibits high specificity and an ultrahigh sensitivity of detecting as low as 0.1 pg mL−1 of KRAS point mutation without prior PCR amplification. Discriminating KRAS gene mutations in lung adenocarcinoma patients at an extremely low detection limit equivalent to 0.12% mutation relative to wild‐type gene is successful. It is envisioned that this nanoparticle‐coupling approach could be routinely applied clinically for ultra‐early diagnosis and monitoring of diverse malignant tumors, thus facilitating the fight against cancer.Keywords
Funding Information
- National Natural Science Foundation of China (51702349)
- Chinese Academy of Sciences
This publication has 36 references indexed in Scilit:
- Direct detection of a BRAF mutation in total RNA from melanoma cells using cantilever arraysNature Nanotechnology, 2013
- Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel SequencingClinical Chemistry, 2013
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome SequencingScience Translational Medicine, 2012
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation StatusJournal of Clinical Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Keeping Tabs on Tumor DNAScience, 2010
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon CancerJournal of Clinical Oncology, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Origin and prognostic value of circulating KRAS mutations in lung cancer patientsCancer Letters, 2007
- Isolation and characterization of DNA from the plasma of cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1987